US Hemp Ban Could Criminalize CBD Products and Derail Medicare Plan

A new hemp ban passed by Congress threatens to criminalize CBD products and undermine a pilot program to reimburse patients for hemp-derived treatments. This legislative move could disrupt access to legitimate medical therapies for patients relying on these compounds. The conflict between federal bans and medical needs highlights the urgent need for clearer regulatory frameworks.